drugset / Trial / NCT00319306

Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy

NCT00319306 ↗

Phase 3 Completed 550 enrolled AstraZeneca
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether patients with asthma are better able to manage and control their symptoms by using one inhaler daily that both prevents as well as treats the symptoms of an asthma exacerbation.

Timeline

Start
2005-09
Primary completion
—
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule — —
Subject Formoterol Other / unclassified — —

Indications